Delivery Order SPE2DB20D2014-SPE2DB25FC68M
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray in 16-gram units. This firm fixed price contract, valued at $1,465.32, represents a non-competitive delivery order with an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves as a child order under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray in 16-gram units. This firm fixed-price delivery order, valued at $2,347.96, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made through open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray in 16-gram units, with a ceiling value of $1,716.74. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This delivery order, awarded on July 21, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Fluticasone Propionate 50 micrograms nasal spray in 16-gram units with a ceiling value of $1,077.75. The contract represents a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. This award was made through open competition with no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,442.40 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 microgram nasal spray in 16-gram units. This firm fixed-price delivery order, issued on July 24, 2025, represents a competitive award with no set-aside designation and is scheduled for ultimate completion by July 25, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,232.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms nasal spray (16 grams) on July 18, 2025, with an ultimate completion date of July 21, 2025. This contract was not designated under any set-aside program and represents a competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,365.73 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on July 22, 2025, with completion scheduled for July 23, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical supply transaction executed under the company's existing contract vehicle with DLA. The award was placed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray in 16-gram units. This firm fixed-price delivery order, valued at $2,630.36, represents a competitively awarded contract with an ultimate completion date of August 11, 2025. The award was placed with AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $2,008.40 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 microgram nasal spray (16 grams) on July 30, 2025, with completion targeted for July 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Fluticasone Propionate 50 mcg nasal spray in 16-gram quantities. This firm fixed-price delivery order, valued at $1,308.96, represents a non-competitive set-aside contract and is scheduled for completion by August 6, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC68MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fluticasone Propionate 50 microgram nasal spray in 16-gram units, with a ceiling value of $1,754.80 and a firm fixed price structure. This non-set-aside delivery order is scheduled for ultimate completion by August 8, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award is classified as a child contract, indicating it derives from a larger contract vehicle. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies critical pharmaceutical products and medical commodities to support military and federal healthcare systems worldwide. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to deliver a broad range of medications, vaccines, medical devices, and specialized healthcare supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/7/25 |